16 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34294550 | The Effects of Cholecalciferol Supplementation on FGF23 and α-Klotho in Hemodialysis Patients With Hypovitaminosis D: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2022 May | 1 |
2 | 33191899 | Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer. | 2021 Feb | 1 |
3 | 29602956 | Effects of vitamin D supplementation on FGF23: a randomized-controlled trial. | 2019 Mar | 1 |
4 | 30888584 | Cholecalciferol supplementation increases FGF23 in peritoneal dialysis patients with hypovitaminosis D: a randomized clinical trial. | 2019 Aug | 1 |
5 | 31044263 | High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis. | 2019 Aug | 1 |
6 | 31372708 | Oral vitamin D3 supplementation increases serum fibroblast growth factor 23 concentration in vitamin D-deficient patients: a systematic review and meta-analysis. | 2019 Nov | 4 |
7 | 28795342 | Effect of Cholecalciferol therapy on serum FGF23 in vitamin D deficient patients: a randomized clinical trial. | 2018 Mar | 2 |
8 | 30269120 | [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.] | 2018 | 1 |
9 | 29179169 | [Bone remodeling through a phosphate metabolism.] | 2017 | 1 |
10 | 29271617 | Effects of Single Vitamin D₃ Injection (200,000 Units) on Serum Fibroblast Growth Factor 23 and Sclerostin Levels in Subjects with Vitamin D Deficiency. | 2017 Dec | 2 |
11 | 26813503 | [Inhitibion of FGF23 activities as a possible new treatment for patients with FGF23-related hypophosphatemic diseases]. | 2016 Feb | 1 |
12 | 26939683 | Fibroblast growth factor-23 and renin-angiotensin system levels in vitamin-D-dependent rickets type I. | 2016 Jul | 2 |
13 | 24466013 | Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism. | 2014 | 2 |
14 | 24960544 | Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol. | 2014 Oct | 4 |
15 | 22822092 | Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. | 2012 Sep | 1 |
16 | 18839328 | Serum fibroblast growth factor-23 levels in chronic haemodialysis patients. | 2009 | 1 |